Hong Kong national security law

Resolve2Win campaign debuts in Bangkok, promoting Hong Kong's legal services

Retrieved on: 
Friday, March 17, 2023

Mr Horace Cheung, Deputy Secretary for Justice, led nearly 30 representatives from Hong Kong's legal sector in face-to-face talks with Thai legal and business representatives to promote the advantages of Hong Kong legal services, encourage collaboration between Hong Kong and Thailand and seize opportunities in the region.

Key Points: 
  • Mr Horace Cheung, Deputy Secretary for Justice, led nearly 30 representatives from Hong Kong's legal sector in face-to-face talks with Thai legal and business representatives to promote the advantages of Hong Kong legal services, encourage collaboration between Hong Kong and Thailand and seize opportunities in the region.
  • The Resolve2Win - Legal Services of Hong Kong, Opportunities for All campaign debuted in Bangkok, Thailand on 15 to 17 March Nearly 30 representatives from the Hong Kong legal sector join the delegation.
  • He further said that as the leading legal and dispute resolution services centre in the Asia-Pacific, Hong Kong had a strong pool of legal talents, particularly in dispute resolution services.
  • The campaign will promote legal and dispute resolution services of Hong Kong in the GBA early next year, showcasing the robust legal system, solid foundation of the rule of law and diversified legal and dispute resolution services in Hong Kong while helping to better understand the views of mainland stakeholders and their needs towards Hong Kong's legal and dispute resolution services.

INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against UP Fintech Holding Limited and Encourages Investors with Losses to Contact the Firm

Retrieved on: 
Thursday, January 5, 2023

The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of UP Fintech Holding Limited (“UP Fintech” or “the Company”) (NASDAQ: TIGR ) for violations of the securities laws.

Key Points: 
  • The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of UP Fintech Holding Limited (“UP Fintech” or “the Company”) (NASDAQ: TIGR ) for violations of the securities laws.
  • The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
  • We also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge.
  • The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against UP Fintech Holding Limited and Encourages Investors with Losses to Contact the Firm

Retrieved on: 
Wednesday, January 4, 2023

The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of UP Fintech Holding Limited (“UP Fintech” or “the Company”) (NASDAQ: TIGR ) for violations of the securities laws.

Key Points: 
  • The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of UP Fintech Holding Limited (“UP Fintech” or “the Company”) (NASDAQ: TIGR ) for violations of the securities laws.
  • The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
  • We also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge.
  • The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

Amylyx Pharmaceuticals Announces Closing of Upsized Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares

Retrieved on: 
Tuesday, October 11, 2022

Amylyx Pharmaceuticals, Inc. (Amylyx) today announced the closing of its previously announced upsized underwritten public offering of 7,697,812 shares of its common stock at a public offering price of $32.00 per share, which includes the exercise in full by the underwriters of their option to purchase up to an additional 1,004,062 shares of common stock in the offering.

Key Points: 
  • Amylyx Pharmaceuticals, Inc. (Amylyx) today announced the closing of its previously announced upsized underwritten public offering of 7,697,812 shares of its common stock at a public offering price of $32.00 per share, which includes the exercise in full by the underwriters of their option to purchase up to an additional 1,004,062 shares of common stock in the offering.
  • The gross proceeds to Amylyx from the offering were $246.3 million, before deducting underwriting discounts and commissions and estimated offering expenses.
  • Goldman Sachs & Co. LLC, BofA Securities, SVB Securities, and Evercore ISI acted as joint book-running managers for the offering.
  • Amylyx Pharmaceuticals, Inc. is committed to supporting and creating more moments for the neurodegenerative community through the discovery and development of innovative new treatments.

Amylyx Pharmaceuticals Announces Pricing of Upsized Public Offering of Common Stock

Retrieved on: 
Friday, October 7, 2022

Amylyx Pharmaceuticals, Inc. (Amylyx) today announced the pricing of an upsized underwritten public offering of 6,693,750 shares of its common stock at a public offering price of $32.00 per share.

Key Points: 
  • Amylyx Pharmaceuticals, Inc. (Amylyx) today announced the pricing of an upsized underwritten public offering of 6,693,750 shares of its common stock at a public offering price of $32.00 per share.
  • All of the shares of common stock are being offered by Amylyx.
  • Amylyx has granted the underwriters a 30-day option to purchase up to an additional 1,004,062 shares of common stock at the public offering price, less underwriting discounts and commissions.
  • The offering is expected to close on or about October 11, 2022, subject to the satisfaction of customary closing conditions.

Governing for prosperity: Hong Kong under 'one country, two systems'

Retrieved on: 
Thursday, June 30, 2022

This is the rationale behind the "one country, two systems" principle, which underpins the common prosperity of Hong Kong and the Chinese mainland.

Key Points: 
  • This is the rationale behind the "one country, two systems" principle, which underpins the common prosperity of Hong Kong and the Chinese mainland.
  • The world has seen a beautiful and prosperous Hong Kong with good governance.
  • The Chinese central government and the rest of the world have greater confidence and trust in Hong Kong.
  • We believe that the institutional system of Hong Kong under the "one country, two systems" principle will be more complete and the institutional norms and social foundation of "patriots administering Hong Kong" will be better consolidated.

Brenmiller Energy Ltd. Shares to Commence Trading on Nasdaq Capital Market; Closes Second Tranche of Private Placement Investment

Retrieved on: 
Tuesday, May 24, 2022

Brenmiller Energy Ltd. (Brenmiller, Brenmiller Energy or the Company) (TASE: BNRG, Nasdaq: BNRG), a clean-energy company that provides Thermal Energy Storage (TES) systems to the global industrial and utility markets, announced today that its ordinary shares have been approved for listing on the Nasdaq Capital Market (Nasdaq).

Key Points: 
  • Brenmiller Energy Ltd. (Brenmiller, Brenmiller Energy or the Company) (TASE: BNRG, Nasdaq: BNRG), a clean-energy company that provides Thermal Energy Storage (TES) systems to the global industrial and utility markets, announced today that its ordinary shares have been approved for listing on the Nasdaq Capital Market (Nasdaq).
  • Brenmillers shares will begin trading on Nasdaq on Wednesday, May 25, 2022, under the ticker symbol BNRG.
  • The Company will maintain the listing of its ordinary shares on the Tel Aviv Stock Exchange under the symbol BNRG.
  • The listing of the Companys shares on the Nasdaq constitutes compliance with the closing requirements of a securities purchase agreement with certain private investors as previously announced on November 2, 2021.

Amylyx Pharmaceuticals Announces Pricing of Upsized Initial Public Offering of Common Stock

Retrieved on: 
Friday, January 7, 2022

Amylyx Pharmaceuticals, Inc. (Amylyx), a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases, today announced the pricing of its upsized initial public offering of 10,000,000 shares of common stock pursuant to registration statements on Form S-1 filed with the U.S. Securities and Exchange Commission (SEC) at an initial public offering price of $19.00 per share.

Key Points: 
  • Amylyx Pharmaceuticals, Inc. (Amylyx), a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases, today announced the pricing of its upsized initial public offering of 10,000,000 shares of common stock pursuant to registration statements on Form S-1 filed with the U.S. Securities and Exchange Commission (SEC) at an initial public offering price of $19.00 per share.
  • All of the shares of common stock are being offered by Amylyx.
  • Amylyx has granted the underwriters a 30-day option to purchase up to an additional 1,500,000 shares of common stock at the initial public offering price, less underwriting discounts and commissions.
  • Amylyx' common stock is expected to begin trading on the Nasdaq Global Select Market under the ticker symbol "AMLX" on January 7, 2022.

Delta Galil Announces Preliminary 2022 Guidance and Reaffirms 2021 Guidance

Retrieved on: 
Wednesday, December 15, 2021

Delta Galil is a global manufacturer and marketer of branded and private label apparel products for men, women and children.

Key Points: 
  • Delta Galil is a global manufacturer and marketer of branded and private label apparel products for men, women and children.
  • Delta Galil also designs, develops markets and sells branded denim and apparel under the brand 7 For All Mankind, and ladies apparel under the brands Splendid and Ella Moss, among others.
  • In addition, it sells its products under brand names licensed to the company, including Wilson, Spalding, Tommy Hilfiger and others.
  • These statements discuss future expectations, contain projections of results of operations or of financial condition or state other forward-looking information.

SPAR Group Reports Results for the Second Quarter Ended June 30, 2021

Retrieved on: 
Tuesday, August 17, 2021

AUBURN HILLS, Mich., Aug. 17, 2021 (GLOBE NEWSWIRE) -- SPAR Group, Inc. (NASDAQ: SGRP), a leading global provider of merchandising and marketing services, today reported financial results for its second quarter ended June 30, 2021.

Key Points: 
  • SPAR Group is a leading global merchandising and marketing services company, providing a broad range of services to retailers, manufacturers and distributors around the world.
  • With more than 40 years of experience, 25,000+ merchandising specialists around the world, an average of 200,000+ store visits a week and long-term relationships with some of the worlds leading manufacturers and retail businesses.
  • SPAR Group provides specialized capabilities across 9 countries and 4 continents.
  • The Company's forward-looking statements also include, in particular and without limitation, those made in "Business", "Risk Factors", "Legal Proceedings", and "Management's Discussion and Analysis of Financial Condition and Results of Operations" in the Annual Report.